Related Experiment Video
Updated: Feb 13, 2026

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
Published on: September 26, 2018
ATRA improves endothelial dysfunction in atherosclerotic rabbits by decreasing CAV‑1 expression and enhancing eNOS
Yan Wu1, Xiaobian Wang2, Qing Zhou2
1Reproductive Medicine Center, 105 Hospital of People's Liberation Army, Hefei, Anhui 230031, P.R. China.
Abstract:
The aim of the present study was to explore the protective effects and possible mechanisms of all‑trans‑retinoic acid (ATRA) against atherosclerosis (AS). Rabbits were randomly allocated for standard or high‑fat diet with or without ATRA. After 12 weeks, the aortic rings of the rabbits were removed. Endothelium‑dependent relaxation (EDR) induced by acetylcholine and non‑endothelium‑dependent relaxation induced by sodium nitroprusside in the thoracic aorta were evaluated. NO level and eNOS activity were measured according to the protocol of NO and eNOS ELISA kits. The permeability and morphology of the arterial walls were identified by immunofluorescence and H&E staining respectively. The expression of caveolin‑1 (CAV‑1) and occludin was analyzed using western blotting and immunohistochemistry. The EDR function was significantly reduced in the AS rabbits compared with the normal group, however it was elevated following treatment with ATRA. The eNOS activity and NO level were reduced in the AS group, however were notably increased following oral administration of ATRA. There was an enhancement of endothelial permeability in the AS group compared with the normal group, which decreased following ATRA treatment. Western blot analysis and immunohistochemical analysis identified an increase in occludin expression after treatment with ATRA, in contrast to CAV‑1 expression under the same conditions. ATRA is able to ameliorate high‑fat‑induced AS in rabbits, which is mediated through the activation of eNOS and downregulating CAV‑1 expression.
Insights
All-trans-retinoic acid (ATRA) protects against atherosclerosis in rabbits by improving blood vessel function and reducing inflammation. ATRA enhances nitric oxide production and lowers key protein expressions linked to arterial damage.
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Pharmacology
Background:
- Atherosclerosis (AS) is a chronic inflammatory disease characterized by plaque buildup in arteries.
- Endothelial dysfunction plays a critical role in AS pathogenesis.
- All-trans-retinoic acid (ATRA) is a vitamin A derivative with potential therapeutic properties.
Purpose of the Study:
- To investigate the protective effects of ATRA against high-fat diet-induced AS in rabbits.
- To elucidate the underlying mechanisms of ATRA's action on endothelial function and arterial integrity.
Main Methods:
- Rabbits were fed a standard or high-fat diet, with or without ATRA, for 12 weeks.
- Evaluated endothelium-dependent and -independent relaxation, nitric oxide (NO) levels, and eNOS activity.
- Assessed arterial wall permeability, morphology, and expression of caveolin-1 (CAV-1) and occludin.
Main Results:
- ATRA treatment significantly improved endothelial-dependent relaxation in AS rabbits.
- ATRA increased NO levels and eNOS activity, while decreasing endothelial permeability.
- ATRA upregulated occludin expression and downregulated CAV-1 expression in the arterial walls.
Conclusions:
- ATRA ameliorates high-fat diet-induced atherosclerosis in rabbits.
- The protective effects are mediated by the activation of eNOS and downregulation of CAV-1.
- ATRA demonstrates potential as a therapeutic agent for atherosclerosis.
Related Concept Videos
Decreasing Function
Decreased Body Temperature
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
Self-Evaluation: Self-Enhancement and Self-Verification
Cell Specific Gene Expression
Bioavailability Enhancement: Drug Solubility Enhancement

